Targeted Treatments for Concussion
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.
Do I need to stop taking my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
How does the Behavioral Control, Targeted Intervention treatment for concussion differ from other treatments?
This treatment is unique because it uses a personalized, dynamic approach tailored to each individual's symptoms, focusing on psychoeducation and cognitive strategy instruction to address cognitive impairments like attention and memory issues. It also involves tracking progress and adapting strategies based on the client's performance, which is not commonly emphasized in other treatments.12345
What data supports the effectiveness of the treatment Behavioral Control, Targeted Intervention for concussion?
Research suggests that using psychoeducation (teaching about the condition) and cognitive strategy instruction (teaching ways to improve thinking skills) can help manage symptoms like attention and memory problems after a concussion. This approach is personalized and adapts to the individual's needs, which may support its effectiveness.16789
Who Is on the Research Team?
Anthony Kontos, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for adults aged 50 or older who have been diagnosed with a concussion within the last 4 days to 12 months. They must be able to read and write for assessments and are recruited at their initial concussion appointment. Those with neurological disorders, major psychiatric conditions other than depression/anxiety, or severe brain injuries/surgery are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive targeted treatments for concussion, including cognitive screening and symptom questionnaires
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of symptom severity and cognitive function
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Control
- Targeted Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor